Advertisement

Vitamin E and Metabolic Syndrome

  • Richard S. BrunoEmail author
Chapter
Part of the Nutrition and Health book series (NH)

Abstract

Obesity-related disorders, such as metabolic syndrome (MetS), type 2 diabetes mellitus, and nonalcoholic fatty liver disease (NAFLD), are on the rise largely due to poor lifestyle in that diets often contain excess energy in association with limited intakes of essential nutrients, including the antioxidant α-tocopherol. Both healthy individuals and those with MetS have poor dietary α-tocopherol intakes that are substantially lower than the RDA; the latter also have compromised α-tocopherol status based on their lipid-normalized concentrations of circulating α-tocopherol. Dysregulated physiological responses, including altered trafficking along the gut-liver axis, in MetS persons further contribute to inadequate α-tocopherol status and provide rationale for increased attention to establish specialized dietary recommendations. α-Tocopherol supplementation at pharmacological doses shows promise in the treatment of MetS-related metabolic disease, including NAFLD. Thus, scientific focus on metabolic aberrations in relation to vitamin E intake, pharmacokinetics, and status may be a more appropriate approach to evaluate α-tocopherol requirements in relation to its health benefits. This chapter will discuss metabolic aberrations, with a focus on MetS persons as a clinical model, on dysregulated α-tocopherol trafficking and catabolism in relation to health benefits and dietary requirements.

Keywords

Metabolic syndrome Nonalcoholic fatty liver disease α-Tocopherol Vitamin E status 

Notes

Acknowledgments

A sincere thanks to Katie England, MS (The Ohio State University, Columbus, OH), for providing editorial assistance. This work was supported by the Ohio Agricultural Research and Development Center at the Ohio State University (Columbus, OH) and a grant from the National Dairy Council.

References

  1. 1.
    Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin J Med. 2008;75:721–8.CrossRefGoogle Scholar
  2. 2.
    Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA. 2015;313:1973–4.CrossRefGoogle Scholar
  3. 3.
    Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev. 2008;29:777–822.CrossRefGoogle Scholar
  4. 4.
    Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care. 2005;28:391–7.CrossRefGoogle Scholar
  5. 5.
    Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force On E, Prevention, Hational Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study Of O. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.CrossRefGoogle Scholar
  6. 6.
    Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.Google Scholar
  7. 7.
    Agarwal S, Reider C, Brooks JR, Fulgoni VL 3rd. Comparison of prevalence of inadequate nutrient intake based on body weight status of adults in the United States: an analysis of NHANES 2001–2008. J Am Coll Nutr. 2015;34:126–34.CrossRefGoogle Scholar
  8. 8.
    Bruno RS, Leonard SW, Atkinson J, Montine TJ, Ramakrishnan R, Bray TM, Traber MG. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic Biol Med. 2006a;40:689–97.CrossRefGoogle Scholar
  9. 9.
    Maras JE, Bermudez OI, Qiao N, Bakun PJ, Boody-Alter EL, Tucker KL. Intake of alpha-tocopherol is limited among US adults. J Am Diet Assoc. 2004;104:567–75.CrossRefGoogle Scholar
  10. 10.
    Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, Esposito K, Jonsson LS, Kolb H, Lansink M, Marcos A, Margioris A, Matusheski N, Nordmann H, O’brien J, Pugliese G, Rizkalla S, Schalkwijk C, Tuomilehto J, Warnberg J, Watzl B, Winklhofer-Roob BM. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106(Suppl 3):S5–78.CrossRefGoogle Scholar
  11. 11.
    U.S. Department of Health and Human Services, U.S. Department of Agriculture. 2015–2020 dietary guidelines for Americans [Online]. 2015. Available: http://health.gov/dietaryguidelines/2015/guidelines/. Accessed 6 Dec 2016.
  12. 12.
    Franz MJ, Boucher JL, Evert AB. Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization. Diabetes Metab Syndr Obes. 2014;7:65–72.CrossRefGoogle Scholar
  13. 13.
    Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr. 2017;6:397–407.CrossRefGoogle Scholar
  14. 14.
    Beltran-Sanchez H, Harhay MO, Harhay MM, Mcelligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J Am Coll Cardiol. 2013;62:697–703.CrossRefGoogle Scholar
  15. 15.
    Meksawan K, Pendergast DR, Leddy JJ, Mason M, Horvath PJ, Awad AB. Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women. J Am Coll Nutr. 2004;23:131–40.CrossRefGoogle Scholar
  16. 16.
    Mueller-Cunningham WM, Quintana R, Kasim-Karakas SE. An ad libitum, very low-fat diet results in weight loss and changes in nutrient intakes in postmenopausal women. J Am Diet Assoc. 2003;103:1600–6.CrossRefGoogle Scholar
  17. 17.
    Freisling H, Noh H, Slimani N, Chajes V, May AM, Peeters PH, Weiderpass E, Cross AJ, Skeie G, Jenab M, Mancini FR, Boutron-Ruault MC, Fagherazzi G, Katzke VA, Kuhn T, Steffen A, Boeing H, Tjonneland A, Kyro C, Hansen CP, Overvad K, Duell EJ, Redondo-Sanchez D, Amiano P, Navarro C, Barricarte A, Perez-Cornago A, Tsilidis KK, Aune D, Ward H, Trichopoulou A, Naska A, Orfanos P, Masala G, Agnoli C, Berrino F, Tumino R, Sacerdote C, Mattiello A, Bueno-De-Mesquita HB, Ericson U, Sonestedt E, Winkvist A, Braaten T, Romieu I, Sabate J. Nut intake and 5-year changes in body weight and obesity risk in adults: results from the EPIC-PANACEA study. Eur J Nutr. 2017;  https://doi.org/10.1007/s00394-017-1513-0.
  18. 18.
    Neale EP, Tapsell LC, Guan V, Batterham MJ. The effect of nut consumption on markers of inflammation and endothelial function: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2017;7:e016863.CrossRefGoogle Scholar
  19. 19.
    Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016;14:207.CrossRefGoogle Scholar
  20. 20.
    Chen GC, Zhang R, Martinez-Gonzalez MA, Zhang ZL, Bonaccio M, Van Dam RM, Qin LQ. Nut consumption in relation to all-cause and cause-specific mortality: a meta-analysis 18 prospective studies. Food Funct. 2017;8:3893–905.CrossRefGoogle Scholar
  21. 21.
    Dhillon J, Tan SY, Mattes RD. Almond consumption during energy restriction lowers truncal fat and blood pressure in compliant overweight or obese adults. J Nutr. 2016;146:2513–9.CrossRefGoogle Scholar
  22. 22.
    U.S. Department of Agriculture ARS, Nutrient Data Laboratory. USDA national nutrient database for standard reference, release 28.Google Scholar
  23. 23.
    Berryman CE, West SG, Fleming JA, Bordi PL, Kris-Etherton PM. Effects of daily almond consumption on cardiometabolic risk and abdominal adiposity in healthy adults with elevated LDL-cholesterol: a randomized controlled trial. J Am Heart Assoc. 2015;4:e000993.CrossRefGoogle Scholar
  24. 24.
    Liu JF, Liu YH, Chen CM, Chang WH, Chen CY. The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial. Eur J Nutr. 2013;52:927–35.CrossRefGoogle Scholar
  25. 25.
    Tan SY, Mattes RD. Appetitive, dietary and health effects of almonds consumed with meals or as snacks: a randomized, controlled trial. Eur J Clin Nutr. 2013;67:1205–14.CrossRefGoogle Scholar
  26. 26.
    Mcburney MI. Majority of Americans not consuming vitamin E RDA. J Nutr. 2011;141:1920.CrossRefGoogle Scholar
  27. 27.
    Mcburney MI, Yu EA, Ciappio ED, Bird JK, Eggersdorfer M, Mehta S. Suboptimal serum alpha-tocopherol concentrations observed among younger adults and those depending exclusively upon food sources, NHANES 2003-20061-3. PLoS One. 2015;10:e0135510.CrossRefGoogle Scholar
  28. 28.
    Sokol RJ, Heubi JE, Iannaccone ST, Bove KE, Balistreri WF. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. N Engl J Med. 1984;310:1209–12.CrossRefGoogle Scholar
  29. 29.
    Traber MG, Mah E, Leonard SW, Bobe G, Bruno RS. Metabolic syndrome increases dietary α-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial. Am J Clin Nutr. 2017;105:571–9.CrossRefGoogle Scholar
  30. 30.
    Mah E, Sapper TN, Chitchumroonchokchai C, Failla ML, Schill KE, Clinton SK, Bobe G, Traber MG, Bruno RS. alpha-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial. Am J Clin Nutr. 2015;102:1070–80.CrossRefGoogle Scholar
  31. 31.
    Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346–52.CrossRefGoogle Scholar
  32. 32.
    Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84:705–12.CrossRefGoogle Scholar
  33. 33.
    Roberts LJ 2nd, Oates JA, Linton MF, Fazio S, Meador BP, Gross MD, Shyr Y, Morrow JD. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007;43:1388–93.CrossRefGoogle Scholar
  34. 34.
    Bruno RS, Leonard SW, Park S, Zhao YY, Traber MG. Human vitamin E requirements assessed with the use of apples fortified with deuterium-labeled alpha-tocopheryl acetate. Am J Clin Nutr. 2006b;83:299–304.CrossRefGoogle Scholar
  35. 35.
    Jeanes YM, Hall WL, Ellard S, Lee E, Lodge JK. The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix. Br J Nutr. 2004;92:575–9.CrossRefGoogle Scholar
  36. 36.
    Leonard SW, Good CK, Gugger ET, Traber MG. Vitamin E bioavailability from fortified breakfast cereal is greater than that from encapsulated supplements. Am J Clin Nutr. 2004;79:86–92.CrossRefGoogle Scholar
  37. 37.
    Bruno RS, Leonard SW, Li J, Bray TM, Traber MG. Lower plasma alpha-carboxyethyl-hydroxychroman after deuterium-labeled alpha-tocopherol supplementation suggests decreased vitamin E metabolism in smokers. Am J Clin Nutr. 2005a;81:1052–9.CrossRefGoogle Scholar
  38. 38.
    Bruno RS, Ramakrishnan R, Montine TJ, Bray TM, Traber MG. {alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. Am J Clin Nutr. 2005b;81:95–103.CrossRefGoogle Scholar
  39. 39.
    Proteggente AR, Turner R, Majewicz J, Rimbach G, Minihane AM, Kramer K, Lodge JK. Noncompetitive plasma biokinetics of deuterium-labeled natural and synthetic alpha-tocopherol in healthy men with an apoE4 genotype. J Nutr. 2005;135:1063–9.CrossRefGoogle Scholar
  40. 40.
    Hall WL, Jeanes YM, Lodge JK. Hyperlipidemic subjects have reduced uptake of newly absorbed vitamin E into their plasma lipoproteins, erythrocytes, platelets, and lymphocytes, as studied by deuterium-labeled alpha-tocopherol biokinetics. J Nutr. 2005;135:58–63.CrossRefGoogle Scholar
  41. 41.
    Terasawa Y, Ladha Z, Leonard SW, Morrow JD, Newland D, Sanan D, Packer L, Traber MG, Farese RV Jr. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E. Proc Natl Acad Sci U S A. 2000;97:13830–4.CrossRefGoogle Scholar
  42. 42.
    Novotny JA, Fadel JG, Holstege DM, Furr HC, Clifford AJ. This kinetic, bioavailability, and metabolism study of RRR-alpha-tocopherol in healthy adults suggests lower intake requirements than previous estimates. J Nutr. 2012;142:2105–11.CrossRefGoogle Scholar
  43. 43.
    Chavez-Jauregui RN, Mattes RD, Parks EJ. Dynamics of fat absorption and effect of sham feeding on postprandial lipema. Gastroenterology. 2010;139:1538–48.CrossRefGoogle Scholar
  44. 44.
    Robertson MD, Parkes M, Warren BF, Ferguson DJ, Jackson KG, Jewell DP, Frayn KN. Mobilisation of enterocyte fat stores by oral glucose in humans. Gut. 2003;52:834–9.CrossRefGoogle Scholar
  45. 45.
    Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993;300:535–43.CrossRefGoogle Scholar
  46. 46.
    Leonard SW, Paterson E, Atkinson JK, Ramakrishnan R, Cross CE, Traber MG. Studies in humans using deuterium-labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production. Free Radic Biol Med. 2005;38:857–66.CrossRefGoogle Scholar
  47. 47.
    Traber MG, Leonard SW, Bobe G, Fu X, Saltzman E, Grusak MA, Booth SL. alpha-Tocopherol disappearance rates from plasma depend on lipid concentrations: studies using deuterium-labeled collard greens in younger and older adults. Am J Clin Nutr. 2015;101:752–9.CrossRefGoogle Scholar
  48. 48.
    Lebold KM, Ang A, Traber MG, Arab L. Urinary alpha-carboxyethyl hydroxychroman can be used as a predictor of alpha-tocopherol adequacy, as demonstrated in the Energetics Study. Am J Clin Nutr. 2012;96:801–9.CrossRefGoogle Scholar
  49. 49.
    Spengler EK, Loomba R. Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc. 2015;90:1233–46.CrossRefGoogle Scholar
  50. 50.
    Pastori D, Baratta F, Carnevale R, Cangemi R, Del Ben M, Bucci T, Polimeni L, Labbadia G, Nocella C, Scardella L, Pani A, Pignatelli P, Violi F, Angelico F. Similar reduction of cholesterol-adjusted vitamin E serum levels in simple steatosis and non-alcoholic steatohepatitis. Clin Transl Gastroenterol. 2015;6:e113.CrossRefGoogle Scholar
  51. 51.
    Chung MY, Yeung SF, Park HJ, Volek JS, Bruno RS. Dietary alpha- and gamma-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. J Nutr Biochem. 2010;21:1200–6.CrossRefGoogle Scholar
  52. 52.
    Sanyal AJ, Chalasani N, Kowdley KV, Mccullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR, Nash CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675–85.CrossRefGoogle Scholar
  53. 53.
    Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Unalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305:1659–68.CrossRefGoogle Scholar
  54. 54.
    Sato K, Gosho M, Yamamoto T, Kobayashi Y, Ishii N, Ohashi T, Nakade Y, Ito K, Fukuzawa Y, Yoneda M. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Nutrition. 2015;31:923–30.CrossRefGoogle Scholar
  55. 55.
    Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ. Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci. 2011;4:158–70.CrossRefGoogle Scholar
  56. 56.
    Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46.CrossRefGoogle Scholar
  57. 57.
    Maki KC, Slavin JL, Rains TM, Kris-Etherton PM. Limitations of observational evidence: implications for evidence-based dietary recommendations. Adv Nutr. 2014;5:7–15.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.The Ohio State UniversityColumbusUSA

Personalised recommendations